| Ident. | Authors (with country if any) | Title |
|---|
| 000007 (2020) |
Zeina W. Sharawi [Arabie saoudite] | Therapeutic effect of Arthrocnemum machrostachyum methanolic extract on Ehrlich solid tumor in mice. |
| 000018 (2020) |
Uddalak Bharadwaj [États-Unis] ; Moses M. Kasembeli [États-Unis] ; Prema Robinson [États-Unis] ; David J. Tweardy | Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution. |
| 000019 (2020) |
Gary J. Haderski ; Bojidar M. Kandar ; Craig M. Brackett ; Ilia M. Toshkov [États-Unis] ; Christopher P. Johnson ; Geraldine M. Paszkiewicz ; Venkatesh Natarajan ; Anatoli S. Gleiberman [États-Unis] ; Andrei V. Gudkov ; Lyudmila G. Burdelya | TLR5 agonist entolimod reduces the adverse toxicity of TNF while preserving its antitumor effects. |
| 000031 (2020) |
Qinghua Wu [République populaire de Chine, République tchèque] ; Wenda Wu [République populaire de Chine, République tchèque] ; Vesna Jacevic [République tchèque, Serbie] ; Tanos C C. Franca [République tchèque, Brésil] ; Xu Wang [République populaire de Chine] ; Kamil Kuca [République tchèque] | Selective inhibitors for JNK signalling: a potential targeted therapy in cancer. |
| 000032 (2020) |
Kamal S. Saini [États-Unis, Royaume-Uni] ; Carlo Lanza [États-Unis] ; Marco Romano [États-Unis] ; Evandro De Azambuja [Belgique] ; Javier Cortes [Espagne, États-Unis] ; Bego A De Las Heras [États-Unis, Espagne] ; Javier De Castro [Espagne] ; Monika Lamba Saini [Belgique] ; Sibylle Loibl [Allemagne] ; Giuseppe Curigliano [Italie] ; Chris Twelves [Royaume-Uni] ; Manuela Leone [États-Unis] ; Mrinal M. Patnaik [États-Unis] | Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy. |
| 000108 (2020) |
Yoshihisa Tokumaru [États-Unis, Japon] ; Kazuaki Takabe [États-Unis] ; Kazuhiro Yoshida [Japon] ; Yukihiro Akao [Japon] | Effects of MIR143 on rat sarcoma signaling networks in solid tumors: A brief overview. |
| 000131 (2020) |
Dinghu Zhang [République populaire de Chine] ; Yanhong Chu [République populaire de Chine] ; Hanqing Qian [République populaire de Chine] ; Lingyu Qian [République populaire de Chine] ; Jie Shao [République populaire de Chine] ; Qiuping Xu [République populaire de Chine] ; Lixia Yu [République populaire de Chine] ; Rutian Li [République populaire de Chine] ; Quanan Zhang [République populaire de Chine] ; Fenglei Wu [République populaire de Chine] ; Baorui Liu [République populaire de Chine] ; Qin Liu [République populaire de Chine] | Antitumor Activity of Thermosensitive Hydrogels Packaging Gambogic Acid Nanoparticles and Tumor-Penetrating Peptide iRGD Against Gastric Cancer. |
| 000175 (2019) |
Arantxa Ortega [Espagne] ; Nuria Olea-Herrero [Espagne] ; M Isabel Arenas [Espagne] ; Esperanza Vélez-Vélez [Espagne] ; Rafael Moreno-G Mez-Toledano [Espagne] ; Carmen Mu Oz-Moreno [Espagne] ; Alberto Lázaro [Espagne] ; Pedro Esbrit [Espagne] ; Alberto Tejedor [Espagne] ; Ricardo J. Bosch [Espagne] | Urinary excretion of parathyroid hormone-related protein correlates with renal function in control rats and rats with cisplatin nephrotoxicity. |
| 000178 (2019) |
Yuxin Lin [République populaire de Chine] ; Jianxin Xu [République populaire de Chine] ; Huiyin Lan [République populaire de Chine, États-Unis] | Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. |
| 000184 (2019) |
Divya Niveditha [Inde] ; Harshita Sharma [Inde] ; Syamantak Majumder [Inde] ; Sudeshna Mukherjee [Inde] ; Rajdeep Chowdhury [Inde] ; Shibasish Chowdhury [Inde] | Transcriptomic analysis associated with reversal of cisplatin sensitivity in drug resistant osteosarcoma cells after a drug holiday. |
| 000185 (2019) |
Fereshteh Shojaei ; Farshad Yazdani-Nafchi ; Mehdi Banitalebi-Dehkordi ; Mohammad Chehelgerdi ; Milad Khorramian-Ghahfarokhi [Iran] | Trace of survivin in cancer. |
| 000188 (2019) |
Malaka Ameratunga [Royaume-Uni] ; Emma Kipps [Royaume-Uni] ; Alicia F C. Okines [Royaume-Uni] ; Juanita S. Lopez [Royaume-Uni] | To Cycle or Fight-CDK4/6 Inhibitors at the Crossroads of Anticancer Immunity. |
| 000194 (2019) |
Hong-Jun Cho [Corée du Sud] ; Sung-Jun Park [Corée du Sud] ; Yoon-Sik Lee [Corée du Sud] ; Sehoon Kim [Corée du Sud] | Theranostic iRGD peptide containing cisplatin prodrug: Dual-cargo tumor penetration for improved imaging and therapy. |
| 000195 (2019) |
Dijana Dra A [Serbie] ; Sanja Mijatovi [Serbie] ; Tamara Krajnovi [Serbie] ; Jelena Bogdanovi Pristov [Serbie] ; Tatjana Uki [Serbie] ; Goran N. Kalu Erovi [Allemagne] ; Ludger A. Wessjohann [Allemagne] ; Danijela Maksimovi Ivani [Serbie] | The synthetic tubulysin derivative, tubugi-1, improves the innate immune response by macrophage polarization in addition to its direct cytotoxic effects in a murine melanoma model. |
| 000222 (2019) |
Jianling Xie [Australie] ; James E. Merrett [Australie] ; Kirk B. Jensen [Australie] ; Christopher G. Proud [Australie] | The MAP kinase-interacting kinases (MNKs) as targets in oncology. |
| 000227 (2019) |
Kuan-Chih Wang [Taïwan] ; Yi-Chang Liu [Taïwan] ; Mohamed El-Shazly [Égypte] ; Shou-Ping Shih [Taïwan] ; Ying-Chi Du [Taïwan] ; Yu-Ming Hsu [Taïwan] ; Hung-Yu Lin [Taïwan] ; Yu-Cheng Chen [Taïwan] ; Yang-Chang Wu [Taïwan] ; Shyh-Chyun Yang [Taïwan] ; Mei-Chin Lu [Taïwan] | The Antioxidant from Ethanolic Extract of Rosa cymosa Fruits Activates Phosphatase and Tensin Homolog In Vitro and In Vivo: A New Insight on Its Antileukemic Effect. |
| 000233 (2019) |
Mohamed Hisham [Égypte] ; Bahaa G M. Youssif [Arabie saoudite] ; Essam Eldin A. Osman [Égypte] ; Alaa M. Hayallah [Égypte] ; Mohamed Abdel-Aziz [Égypte] | Synthesis and biological evaluation of novel xanthine derivatives as potential apoptotic antitumor agents. |
| 000234 (2019) |
Zhen Guo [République populaire de Chine] ; Xiaowei Song [République populaire de Chine] ; Li-Min Zhao [République populaire de Chine] ; Ming Guan Piao [République populaire de Chine] ; Jishan Quan [République populaire de Chine] ; Hu-Ri Piao [République populaire de Chine] ; Cheng Hua Jin [République populaire de Chine] | Synthesis and biological evaluation of novel benzo[c][1,2,5]thiadiazol-5-yl and thieno[3,2-c]- pyridin-2-yl imidazole derivatives as ALK5 inhibitors. |
| 000235 (2019) |
Jinhua Chi [République populaire de Chine] ; Zhiwen Jiang [République populaire de Chine] ; Jing Qiao [République populaire de Chine] ; Yanfei Peng [République populaire de Chine] ; Wanshun Liu [République populaire de Chine] ; Baoqin Han [République populaire de Chine] | Synthesis and anti-metastasis activities of norcantharidin-conjugated carboxymethyl chitosan as a novel drug delivery system. |
| 000240 (2019) |
Yen-Ju Lee [République populaire de Chine] ; Jing-Gung Chung [République populaire de Chine] ; Yi-Ting Chien [République populaire de Chine] ; Song-Shei Lin [République populaire de Chine] ; Fei-Ting Hsu [République populaire de Chine] | Suppression of ERK/NF-κB Activation Is Associated With Amentoflavone-Inhibited Osteosarcoma Progression In Vivo. |
| 000251 (2019) |
Elaine M. Oberlick [États-Unis] ; Matthew G. Rees [États-Unis] ; Brinton Seashore-Ludlow [Suède] ; Francisca Vazquez [États-Unis] ; Geoffrey M. Nelson [États-Unis] ; Neekesh V. Dharia [États-Unis] ; Barbara A. Weir [États-Unis] ; Aviad Tsherniak [États-Unis] ; Mahmoud Ghandi [États-Unis] ; John M. Krill-Burger [États-Unis] ; Robin M. Meyers [États-Unis] ; Xiaofeng Wang [États-Unis] ; Phil Montgomery [États-Unis] ; David E. Root [États-Unis] ; Jake M. Bieber [États-Unis] ; Sandi Radko [États-Unis] ; Jaime H. Cheah [États-Unis] ; C Suk-Yee Hon [États-Unis] ; Alykhan F. Shamji [États-Unis] ; Paul A. Clemons [États-Unis] ; Peter J. Park [États-Unis] ; Michael A. Dyer [États-Unis] ; Todd R. Golub [États-Unis] ; Kimberly Stegmaier [États-Unis] ; William C. Hahn [États-Unis] ; Elizabeth A. Stewart [États-Unis] ; Stuart L. Schreiber [États-Unis] ; Charles W M. Roberts [États-Unis] | Small-Molecule and CRISPR Screening Converge to Reveal Receptor Tyrosine Kinase Dependencies in Pediatric Rhabdoid Tumors. |
